Patent · US Active

Assay for PCSK9 inhibitors

US8206943B1 · kind B1 · utility

2Cited by
1References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 29, 2009
Grant dateJun 26, 2012
Priority date
Expiry dateSep 10, 2030

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/044
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The present invention provides methods for identifying modulators of PCSK9, for example, using a variety of assay formats. Inhibitors of PCSK9 can be used for example, to treat diseases such as hyperlipidemia and related disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.